151 related articles for article (PubMed ID: 38630148)
21. Effects of oncological treatments on semen quality in patients with testicular neoplasia or lymphoproliferative disorders.
Di Bisceglie C; Bertagna A; Composto ER; Lanfranco F; Baldi M; Motta G; Barberis AM; Napolitano E; Castellano E; Manieri C
Asian J Androl; 2013 May; 15(3):425-9. PubMed ID: 23542137
[TBL] [Abstract][Full Text] [Related]
22. Fertility and reproductive technology use in testicular cancer survivors in Japan: A multi-institutional, cross-sectional study.
Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Yamada S; Nishimura K; Nonomura N; Kojo K; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2021 Oct; 28(10):1047-1052. PubMed ID: 34278620
[TBL] [Abstract][Full Text] [Related]
23. The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network.
Rives N; Perdrix A; Hennebicq S; Saïas-Magnan J; Melin MC; Berthaut I; Barthélémy C; Daudin M; Szerman E; Bresson JL; Brugnon F; Bujan L
J Androl; 2012; 33(6):1394-401. PubMed ID: 22837112
[TBL] [Abstract][Full Text] [Related]
24. Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?
Fosså SD; Aass N; Molne K
Br J Urol; 1989 Nov; 64(5):524-9. PubMed ID: 2611625
[TBL] [Abstract][Full Text] [Related]
25. Assessment of sperm quality, DNA integrity and cryopreservation protocols in men diagnosed with testicular and systemic malignancies.
Said TM; Tellez S; Evenson DP; Del Valle AP
Andrologia; 2009 Dec; 41(6):377-82. PubMed ID: 19891636
[TBL] [Abstract][Full Text] [Related]
26. Do malignant diseases affect semen quality? Sperm parameters of men with cancers.
Caponecchia L; Cimino G; Sacchetto R; Fiori C; Sebastianelli A; Salacone P; Marcucci I; Tomassini S; Rago R
Andrologia; 2016 Apr; 48(3):333-40. PubMed ID: 26173956
[TBL] [Abstract][Full Text] [Related]
27. Fertility managment in testicular cancer: the need to establish a standardized and evidence-based patient-centric pathway.
Moody JA; Ahmed K; Yap T; Minhas S; Shabbir M
BJU Int; 2019 Jan; 123(1):160-172. PubMed ID: 29920910
[TBL] [Abstract][Full Text] [Related]
28. Sperm cryopreservation does not affect live birth rate in normozoospermic men: analysis of 7969 oocyte donation cycles.
Torra-Massana M; Vassena R; Rodríguez A
Hum Reprod; 2023 Mar; 38(3):400-407. PubMed ID: 36661036
[TBL] [Abstract][Full Text] [Related]
29. Semen quality and cryopreservation in adolescent cancer patients.
Bahadur G; Ling KL; Hart R; Ralph D; Wafa R; Ashraf A; Jaman N; Mahmud S; Oyede AW
Hum Reprod; 2002 Dec; 17(12):3157-61. PubMed ID: 12456617
[TBL] [Abstract][Full Text] [Related]
30. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania.
Chung K; Irani J; Knee G; Efymow B; Blasco L; Patrizio P
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113 Suppl 1():S7-11. PubMed ID: 15041122
[TBL] [Abstract][Full Text] [Related]
31. [Status quo of autologous sperm preservation in the human sperm bank in Beijing].
Zhou F; Xue JF; Guo Y; Wang XW; Fu LL; Lu WH; Yuan D; Gu YQ; Liang XW
Zhonghua Nan Ke Xue; 2019 Aug; 25(8):719-723. PubMed ID: 32227715
[TBL] [Abstract][Full Text] [Related]
32. Effects of cancer on spermatozoa quality after cryopreservation: a 12-year experience.
Padron OF; Sharma RK; Thomas AJ; Agarwal A
Fertil Steril; 1997 Feb; 67(2):326-31. PubMed ID: 9022611
[TBL] [Abstract][Full Text] [Related]
33. A patient-centric pathway for testicular cancer - A multicentre study investigating the uptake of semen cryopreservation and impact on treatment.
Scott C; Omar K; Alnajjar HM; Alifrangis C; Ahmed K; Muneer A
Andrology; 2021 May; 9(3):823-828. PubMed ID: 33527714
[TBL] [Abstract][Full Text] [Related]
34. Effect of lipid peroxidation on cryopreserved semen quality in patients with testicular or nontesticular cancer.
Wang Y; Sharma RK; Agarwal A
Urology; 1997 Sep; 50(3):414-7. PubMed ID: 9301707
[TBL] [Abstract][Full Text] [Related]
35. Gonadal dysfunction in male cancer patients before cytotoxic treatment.
van Casteren NJ; Boellaard WP; Romijn JC; Dohle GR
Int J Androl; 2010 Feb; 33(1):73-9. PubMed ID: 19538481
[TBL] [Abstract][Full Text] [Related]
36. Preservation of sperm of cancer patients: extent of use and pregnancy outcome in a tertiary infertility center.
Botchan A; Karpol S; Lehavi O; Paz G; Kleiman SE; Yogev L; Yavetz H; Hauser R
Asian J Androl; 2013 May; 15(3):382-6. PubMed ID: 23524529
[TBL] [Abstract][Full Text] [Related]
37. Semen parameters in patients with unilateral testicular cancer compared to patients with other malignancies.
Bussen S; Sütterlin M; Steck T; Dietl J
Arch Gynecol Obstet; 2004 Mar; 269(3):196-8. PubMed ID: 12898144
[TBL] [Abstract][Full Text] [Related]
38. Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancer.
Bager L; Elsbernd A; Nissen A; Daugaard G; Pappot H
Health Qual Life Outcomes; 2018 Jun; 16(1):128. PubMed ID: 29914500
[TBL] [Abstract][Full Text] [Related]
39. Semen cryopreservation in men undergoing cancer treatment: a ten-year study.
Melli B; Morini D; Daolio J; Nicoli A; Valli B; Capodanno F; Spaggiari G; Aguzzoli L; Villani MT; Santi D; Sileo FG
Minerva Obstet Gynecol; 2023 Jun; 75(3):227-235. PubMed ID: 35107238
[TBL] [Abstract][Full Text] [Related]
40. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
